Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation

[1]  Keith C. Norris,et al.  Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R. Zager.  Acquired cytoresistance in the setting of hematopoietic cell transplantation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[3]  T. Spitzer,et al.  Hematopoietic stem cell transplantation in patients with chronic kidney disease. , 2010, Seminars in nephrology.

[4]  Alison M. MacLeod.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) , 2009 .

[5]  G. Beck,et al.  Factors other than glomerular filtration rate affect serum cystatin C levels. , 2009, Kidney international.

[6]  L. Verdonck,et al.  Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Sorror,et al.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. , 2007, Blood.

[8]  C. Parikh,et al.  Acute renal failure in hematopoietic cell transplantation. , 2006, Kidney international.

[9]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.

[10]  D. Spiegelman,et al.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.

[11]  F. Hoek,et al.  A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Zager,et al.  The mevalonate pathway during acute tubular injury: selected determinants and consequences. , 2002, The American journal of pathology.

[14]  W. Bennett,et al.  Renal cholesterol accumulation: a durable response after acute and subacute renal insults. , 2001, The American journal of pathology.

[15]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[16]  T. Tarpey.  Self-Consistency and Principal Component Analysis , 1999 .

[17]  R. Zager,et al.  Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[19]  G. Schoch,et al.  Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. , 2005, Kidney international.

[20]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[21]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.